Dr. Hari Kotturi
My Social Links

Dr. Hari Kotturi

Professor
Clemson University, USA

Highest Degree
Ph.D. in Microbiology from Clemson University, USA

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Microbiology
62%
Bacteriology
90%
Virology
75%
Molecular Biology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Heidari, F., M. Razavi, M.E. Bahrololoom, M. Yazdimamaghani, M. Tahriri, H. Kotturi and L. Tayebi, 2018. Evaluation of the mechanical properties, in vitro biodegradability and cytocompatibility of natural chitosan/hydroxyapatite/nano-Fe3O4 composite. Ceram. Int., 44: 275-281.
    CrossRef  |  Direct Link  |  
  2. Abuabed, A., H. Zafar, E. Sawyer, B. Pallipparambil, H. Jamadagni and M. Khandaker, 2017. Evaluation of polyethylene glycol diacrylate-polycaprolactone scaffolds for tissue engineering applications. J. Funct. Biomater, Vol. 8. 10.3390/jfb8030039.
    CrossRef  |  Direct Link  |  
  3. Kotturi, H., G. Waris, A. Mohammed, P. Chandrakesan, R. May and N. Ali, 2016. (Z)-3,5,4'-trimethoxystilbene limits hepatitis c and cancer pathophysiology by blocking microtubule dynamics and cell-cycle progression. Cancer Res., 76: 4887-4896.
  4. Heidari, F., M. Razavi, M.E. Bahrololoom, R. Bazargan-Lari, D. Vashaee, H. Kotturi and L. Tayebi, 2016. Mechanical properties of natural chitosan/hydroxyapatite/magnetite nanocomposites for tissue engineering applications. Mater. Sci. Eng., 65: 338-344.
    CrossRef  |  Direct Link  |  
  5. Yazdimamaghani, M., M. Razavi, M. Mozafari, D. Vashaee, H. Kotturi and L. Tayebi, 2015. Biomineralization and biocompatibility studies of bone conductive scaffolds containing poly (3, 4-ethylenedioxythiophene): Poly (4-styrene sulfonate) (PEDOT: PSS). J. Mater. Sci.: Mater. Med., Vol. 26. 10.1007/s10856-015-5599-8.
    CrossRef  |  
  6. Rad, T.A., N. Ali, H.S.R. Kotturi, M. Yazdimamaghani, J. Smay, D. Vashaee and L. Tayebi, 2014. Conducting scaffolds for liver tissue engineering. J. Biomed. Mater. Res. Part A, 102: 4169-4181.
    CrossRef  |  Direct Link  |  
  7. Wei, Y., J. Li and H. Kotturi, 2011. Cancer Gene Therapy Via NKG2D and FAS Pathways. In: Targets in gene therapy, You, Y.,( Ed.). InTech Publisher, Croatia, pp:244-248.
  8. Kotturi, H.S.R., J. Li, M. Branham-O'Connor, X. Yu, T.E. Wagner and Y. Wei, 2010. In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors. Cancer gene therapy, 17: 164-170.
    Direct Link  |  
  9. Branham-O'Connor, M., J. Li, H.S. Kotturi, X. Yu, T.E. Wagner and Y. Wei, 2010. Fusion induced reversal of dendritic cell maturation: An altered expression of inflammatory chemokine and chemokine receptors in dendritomas. Oncol. Rep., 23: 545-550.
    CrossRef  |  Direct Link  |  
  10. Kotturi, H., J. Li, M. Branham-O'Connor, S.L. Stickel, X. Yu, T.E. Wagner and Y. Wei, 2008. Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation. Gene Ther., 15: 1302-1310.
    CrossRef  |  Direct Link  |